ScienceGate Book Chapters
Search
About Us
Search
About Us
JOURNAL ARTICLE
Cytarabine/daunorubicin
Year:
2022
Journal:
Reactions Weekly
Vol:
1926 (1)
Pages:
192-192
Publisher:
Adis, Springer Healthcare
DOI:
10.1007/s40278-022-24470-8
Get Full-Text PDF
Get Analytical Report
Keywords:
Daunorubicin
Cytarabine
Medicine
Pharmacology
Internal medicine
Leukemia
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
1
Refs
0.28
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Chemotherapy-related skin toxicity
Health Sciences → Medicine → Dermatology
Chronic Lymphocytic Leukemia Research
Health Sciences → Medicine → Genetics
Fungal Infections and Studies
Health Sciences → Medicine → Epidemiology
Related Documents
JOURNAL ARTICLE
Daunorubicin see Cytarabine/daunorubicin
&NA;
Journal:
Reactions Weekly
Year:
1991
Vol:
&NA; (354)
Pages:
8-8
JOURNAL ARTICLE
Cytarabine/cytarabine/daunorubicin/etoposide
Journal:
Reactions Weekly
Year:
2022
Vol:
1917 (1)
Pages:
201-201
JOURNAL ARTICLE
Cytarabine/daunorubicin
&NA;
Journal:
Reactions Weekly
Year:
2010
Vol:
&NA; (1294)
Pages:
16-16
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal:
Reactions Weekly
Year:
2015
Vol:
1545 (1)
Pages:
84-84
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal:
Reactions Weekly
Year:
2022
Vol:
1907 (1)
Pages:
161-161